Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Other financing activities (2020 - 2022)

Inventiva (IVEVF) posted Other financing activities of -$3.6 million for Q4 2022, down 197.78% on a QoQ basis from $3.7 million in Q3 2022.

Analysis

Inventiva (IVEVF) Other financing activities (2020 - 2022) Analysis & Trends

Inventiva has reported Other financing activities for 2 years, with the latest figure at -$3.6 million in Q4 2022.

  • On a quarterly basis, Other financing activities changed N/A year-over-year to -$3.6 million in Q4 2022; TTM through Dec 2022 was $9.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.7 million, changed 0.39% from the prior year.
  • Other financing activities was -$3.6 million for Q4 2022 at Inventiva, down from $3.7 million in the prior quarter.
  • The five-year high for Other financing activities was $4.7 million in Q2 2020, with the low at -$3.6 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.04 Bn 624.28 Bn 17.26 Bn
2 AbbVie 440.25 Bn 433.68 Bn 12.70 Bn
3 Merck 365.65 Bn 358.51 Bn 12.21 Bn
4 Novartis Ag 266.64 Bn 258.95 Bn 11.24 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.19 Bn 44.19 Bn -
8 Incyte 25.29 Bn 20.75 Bn 1.57 Bn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn
10 Inventiva 693.72 Mn 693.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -3.62 Mn
Sep 22, 2022 3.71 Mn
Jun 30, 2020 4.69 Mn
Mar 31, 2020 4.60 Mn